These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33932621)

  • 1. Alterations of a serum marker of collagen X in growing children with osteogenesis imperfecta.
    Nicol LE; Coghlan RF; Cuthbertson D; Nagamani SCS; Lee B; Olney RC; Horton W; ; Orwoll E
    Bone; 2021 Aug; 149():115990. PubMed ID: 33932621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type V osteogenesis imperfecta: a new form of brittle bone disease.
    Glorieux FH; Rauch F; Plotkin H; Ward L; Travers R; Roughley P; Lalic L; Glorieux DF; Fassier F; Bishop NJ
    J Bone Miner Res; 2000 Sep; 15(9):1650-8. PubMed ID: 10976985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoplasmic reticulum stress is induced in growth plate hypertrophic chondrocytes in G610C mouse model of osteogenesis imperfecta.
    Scheiber AL; Guess AJ; Kaito T; Abzug JM; Enomoto-Iwamoto M; Leikin S; Iwamoto M; Otsuru S
    Biochem Biophys Res Commun; 2019 Jan; 509(1):235-240. PubMed ID: 30579604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pubertal growth in osteogenesis imperfecta caused by pathogenic variants in COL1A1/COL1A2.
    Robinson ME; Rauch D; Glorieux FH; Rauch F
    Genet Med; 2022 Sep; 24(9):1920-1926. PubMed ID: 35657380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal growth curves for children with classical osteogenesis imperfecta (types III and IV) caused by structural pathogenic variants in type I collagen.
    Barber LA; Abbott C; Nakhate V; Do AND; Blissett AR; Marini JC
    Genet Med; 2019 May; 21(5):1233-1239. PubMed ID: 30270360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widespread disturbance in extracellular matrix collagen biomarker responses to teriparatide therapy in osteogenesis imperfecta.
    Nicol L; Srikanth P; Henriksen K; Sun S; Smith R; Karsdal MA; Nagamani SCS; Shapiro J; Lee B; Leder BZ; Orwoll E
    Bone; 2021 Jan; 142():115703. PubMed ID: 33099032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen.
    Marini JC; Hopkins E; Glorieux FH; Chrousos GP; Reynolds JC; Gundberg CM; Reing CM
    J Bone Miner Res; 2003 Feb; 18(2):237-43. PubMed ID: 12568401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in children with osteogenesis imperfecta: a large-sample study.
    Song Y; Zhao D; Li L; Lv F; Wang O; Jiang Y; Xia W; Xing X; Li M
    Osteoporos Int; 2019 Feb; 30(2):461-468. PubMed ID: 30569229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional and longitudinal analysis of bone age maturation during peri-pubertal growth in children with type I, III and IV osteogenesis imperfecta.
    Nicol LE; Baines H; Koike S; Liu W; ; Orwoll E
    Bone; 2024 Jul; 187():117192. PubMed ID: 38969279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme histochemical localisation of alkaline phosphatase activity in osteogenesis imperfecta bone and growth plate: a preliminary study.
    Sarathchandra P; Cassella JP; Ali SY
    Micron; 2005; 36(7-8):715-20. PubMed ID: 16182549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in non-type I collagen biomarkers in osteogenesis imperfecta.
    Nicol L; Morar P; Wang Y; Henriksen K; Sun S; Karsdal M; Smith R; Nagamani SCS; Shapiro J; Lee B; Orwoll E
    Bone; 2019 Mar; 120():70-74. PubMed ID: 30290234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Popcorn calcification in osteogenesis imperfecta: incidence, progression, and molecular correlation.
    Obafemi AA; Bulas DI; Troendle J; Marini JC
    Am J Med Genet A; 2008 Nov; 146A(21):2725-32. PubMed ID: 18798308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel variant of osteogenesis imperfecta type IV and low serum phosphorus level caused by a Val94Asp mutation in COL1A1.
    Yang Q; Xu H; Luo J; Zhang Q; Xie B; Yi S; Rong X; Wang J; Qin Z; Jiang T; Lin L; Zuo Y; Fan X
    Mol Med Rep; 2018 Mar; 17(3):4433-4439. PubMed ID: 29344653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation.
    Blouin S; Fratzl-Zelman N; Glorieux FH; Roschger P; Klaushofer K; Marini JC; Rauch F
    J Bone Miner Res; 2017 Sep; 32(9):1884-1892. PubMed ID: 28548288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect.
    Glorieux FH; Ward LM; Rauch F; Lalic L; Roughley PJ; Travers R
    J Bone Miner Res; 2002 Jan; 17(1):30-8. PubMed ID: 11771667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Static and dynamic bone histomorphometry in children with osteogenesis imperfecta.
    Rauch F; Travers R; Parfitt AM; Glorieux FH
    Bone; 2000 Jun; 26(6):581-9. PubMed ID: 10831929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a Role for Nanoporosity and Pyridinoline Content in Human Mild Osteogenesis Imperfecta.
    Paschalis EP; Gamsjaeger S; Fratzl-Zelman N; Roschger P; Masic A; Brozek W; Hassler N; Glorieux FH; Rauch F; Klaushofer K; Fratzl P
    J Bone Miner Res; 2016 May; 31(5):1050-9. PubMed ID: 26748579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of longitudinal bone growth in osteogenesis imperfecta using metacarpophalangeal pattern profiles.
    Rauch D; Robinson ME; Seiltgens C; Sutton VR; Lee B; Glorieux F; Rauch F
    Bone; 2020 Nov; 140():115547. PubMed ID: 32730936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.
    Lindahl K; Kindmark A; Rubin CJ; Malmgren B; Grigelioniene G; Söderhäll S; Ljunggren Ö; Åström E
    Bone; 2016 Jun; 87():11-8. PubMed ID: 26957348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineral particle size in children with osteogenesis imperfecta type I is not increased independently of specific collagen mutations.
    Fratzl-Zelman N; Schmidt I; Roschger P; Glorieux FH; Klaushofer K; Fratzl P; Rauch F; Wagermaier W
    Bone; 2014 Mar; 60():122-8. PubMed ID: 24296239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.